| Record ID | ia:targetedtherapyf0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/targetedtherapyf0000unse/targetedtherapyf0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/targetedtherapyf0000unse/targetedtherapyf0000unse_meta.mrc |
LEADER: 01407cam a22003977a 4500
001 2003535344
003 DLC
005 20060804102147.0
008 030425s2003 enkaf b 001 0 eng
010 $a 2003535344
015 $aGBA2-W6529
016 7 $a101167536$2DNLM
020 $a0198508964 (hbk. : alk. paper)
035 $a(OCoLC)ocm50055138
040 $aNLM$cNLM$dUKM$dDLC
042 $alccopycat
050 00 $aRC271.I45$bT37 2003
060 00 $a2003 C-022
060 10 $aQZ 266$bT185 2003
082 04 $a616.99406$221
245 00 $aTargeted therapy for cancer /$cedited by Konstantinos N. Syrigos and Kevin J. Harrington.
260 $aOxford ;$aNew York :$bOxford University Press,$c2003.
300 $axviii, 343 p., [4] p. of plates :$bill. (some col.) ;$c26 cm.
504 $aIncludes bibliographical references and index.
650 0 $aCancer$xImmunotherapy.
650 0 $aCancer$xRadioimmunotherapy.
650 0 $aCancer$xGene therapy.
650 0 $aDrug targeting.
650 12 $aNeoplasms$xtherapy.
650 22 $aAntibodies, Monoclonal.
650 22 $aGene Therapy.
650 22 $aImmunotherapy.
700 1 $aSyrigos, Konstantinos N.
700 1 $aHarrington, Kevin J.,$d1958-
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0616/2003535344-d.html
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/enhancements/fy0616/2003535344-t.html